Axogen
NASDAQ: AXGN1 known investors
Find your way into Axogen
93 people in our graph share verified history with the Axogen team — schools, employers, funds. One of them is your warm intro.
Kevin Bittermanunlockedknows Michael Dale · together at Neuronetics, Inc. (overlapped)
×2knows the team · via Rhythmia Medical, Inc.
knows the team · via ATS Medical, Inc.
×4knows the team · via Neochord
×4knows the team · via Edwards Lifesciences
Axogen develops and commercializes technologies for peripheral nerve regeneration and repair, offering clinically proven surgical solutions to restore feeling and function to damaged nerves. Its products serve surgeons and healthcare providers treating patients with peripheral nerve damage.
Founders & leadership
MD
Michael DaleinDirector, Chief Executive Officer and PresidentPresident, Chief Executive Officer and Board Director at Axogeninc
Investors · 1
Funding
SEC filings, press & company announcements$200M disclosed across 1 round · 2026
- $200MraisedSep 2026 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Healthcare News, Deals, and Investments Update September 14th, 2026 - Lawrence, Evans & Co. LLClawrenceevans.com · Sep 2026
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repairfinance.yahoo.com · Sep 2026Frequently asked questions
- What does Axogen do?
- Axogen develops and commercializes technologies for peripheral nerve regeneration and repair, offering clinically proven surgical solutions to restore feeling and function to damaged nerves. Its products serve surgeons and healthcare providers treating patients with peripheral nerve damage.
- Who are Axogen's investors?
- Axogen's investors include Essex Woodlands Healthcare Partners.
- How much funding has Axogen raised?
- Axogen has disclosed $200M raised across 1 round.